

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.524, 2007-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Immunisation rates increase with threat of sanctions
Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. :




A meta-analysis has found no increase in cancer rates with certolizumab pegol or golimumab
Reactions Weekly, Vol. 1, Iss. 1398, 2012-01 ,pp. :

